Who
George Bickerstaff
Director
Company insider
Files Form 4 as: Director, CareDx; Director, Innoviva; Director, Axovant Sciences; Director, Inovio Pharmaceuticals; Director, Ariad Pharmaceuticals; Director, Vion Pharmaceuticals; Director, BMP Sunstone.
In numbers
- Trades disclosed
- 136
- Buys
- 7
- Sells
- 7
- Bought
- $829K
- Sold
- $5.6M
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 28 Jun 2006
- Last trade
- 5 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $926K20,000 at $46.29 | filing |
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $926K20,000 at $46.29 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —29,136 at $0.00 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $232K29,136 at $7.96 | filing |
| 13 Jun 2025filed 17 Jun 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —12,103 at $0.00 | filing |
| 10 Mar 2025filed 12 Mar 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $367K20,000 at $18.36 | filing |
| 1 Nov 2024filed 5 Nov 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —5,255 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,226 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $31K5,255 at $5.85 | filing |
| 1 Nov 2024filed 5 Nov 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $12K2,226 at $5.49 | filing |
| 14 Jun 2024filed 20 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,048 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,048 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —10,570 at $0.00 | filing |
| 14 May 2024filed 16 May 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —5,255 at $0.00 | filing |
| 14 May 2024filed 16 May 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code M | $53K5,255 at $10.00 | filing |
| 11 Aug 2023filed 11 Aug 2023 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —5,255 at $0.00 | filing |
| 11 Aug 2023filed 11 Aug 2023 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —9,745 at $0.00 | filing |
| 11 Aug 2023filed 11 Aug 2023 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,453 at $0.00 | filing |
News
Analyzing CollPlant Biotechnologies (NASDAQ:CLGN) and CareDx (NASDAQ:CDNA)CDNA · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name George Bickerstaff; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.